Slow Bull
The market, slowly. FRIDAY, 25 SEPTEMBER 2026

XBiotech Inc.

XBIT Nasdaq SEC CIK 1626878
Follow XBiotech Weekly email: filings, results, news

Financials

Reported figures only · latest: Q2 2026 USD · US GAAP
Net income −$6.7M −283.1% vs same quarter last year
EPS, diluted −$0.22 −266.7% vs same quarter last year
Operating cash flow −$4.5M +24.6% vs same quarter last year
Operating income −$6.1M +3% vs same quarter last year
Net income by quarter
−$5M
−$10.5M
−$10.9M
−$1.8M
−$6M
−$26.9M
−$5.5M
−$6.7M
Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income14 fiscal years
  • Revenue
  • Net income
−$200M$0$200M$400M$600M$800MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25-−$45.5M
FY24-−$38.5M
FY23$0−$24.6M
FY22$4M−$32.9M
FY21$18.4M−$17.4M
FY20$44M−$11.2M
FY19$0$668.6M
FY18$0−$21.1M
FY17-−$33.2M
FY16-−$52.8M
FY15-−$37.5M
FY14-−$21.7M
FY13-−$9.9M
FY12--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−1000%−750%−500%−250%0%250%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25---
FY24---
FY23---
FY2283.8%−860.1%−820.4%
FY2168.4%−136.4%−94.7%
FY2021.5%−41.5%−25.5%
FY19---
FY18---
FY17---
FY16---
FY15---
FY14---
FY13---
FY12---
Free cash flowOperating cash flow minus capital expenditure
−$100M−$50M$0$50M$100MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$40.2M
FY24−$32.3M
FY23−$19.1M
FY22−$15.4M
FY21$65.9M
FY20−$68.9M
FY19−$18.5M
FY18−$16.7M
FY17−$35.1M
FY16−$50.8M
FY15−$35.6M
FY14−$13.1M
FY13−$9M
FY12-
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$20M$40M$60M$80MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25--
FY24-$0
FY23-$14K
FY22$0$0
FY21$75M-
FY20$0-
FY19$0-
FY18--
FY17--
FY16--
FY15--
FY14--
FY13--
FY12--
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • XBiotech
  • Healthcare median
−1000%−750%−500%−250%0%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearXBiotechHealthcare median
FY25-−40.6%
FY24-−60.7%
FY23-−97.1%
FY22−820.4%−128.5%
FY21−94.7%−129.2%
FY20−25.5%−136.5%
FY19-−133.7%
FY18-−173.4%
FY17-−176.7%
FY16-−164.8%
FY15-−183.4%
FY14-−133%
FY13-−88.5%
FY12-−87.4%

News

No stories filed under XBiotech yet - coverage appears here as the news feed clusters it.